cilomilast has been researched along with zardaverine in 9 studies
| Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (zardaverine) | Trials (zardaverine) | Recent Studies (post-2010) (zardaverine) |
|---|---|---|---|---|---|
| 162 | 13 | 42 | 67 | 2 | 22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hatzelmann, A; Sterk, GJ; Thibaut, U; Timmerman, H; Van der Laan, IJ; Van der Mey, M | 1 |
| Bommelé, KM; Boss, H; Hatzelmann, A; Sterk, GJ; Timmerman, H; Van der Mey, M; Van Slingerland, M | 1 |
| Artis, DR; Bollag, G; Card, GL; England, BP; Fong, D; Gillette, S; Ibrahim, PN; Kim, SH; Lee, B; Luu, C; Milburn, MV; Powell, B; Schlessinger, J; Suzuki, Y; Tabrizizad, M; Zhang, KY | 1 |
| Jabaris, SS; Kodimuthali, A; Pal, M | 1 |
| Barlow, DJ; Ehrman, TM; Hylands, PJ | 1 |
| Barreiro, EJ; Bourguignon, JJ; Cardozo, SV; Fraga, CA; Justiniano, H; Kümmerle, AE; Lopes, AB; Lugnier, C; Martins, MA; Romeiro, NC; Schmitt, M; Villa, P | 1 |
| de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R | 1 |
| Bielska, M; Bruno, O; Bull, JA; Fossa, P; Giordanetto, F; Guariento, S; Iwanowa, X; Karawajczyk, A; Marchini, G | 1 |
| He, J; Ke, H; Peng, T; Qi, B; Shi, J | 1 |
2 review(s) available for cilomilast and zardaverine
| Article | Year |
|---|---|
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2008 |
Advances in the Development of Phosphodiesterase-4 Inhibitors.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Molecular Structure; Phosphodiesterase 4 Inhibitors; Protein Conformation; Quinolones; Vomiting | 2020 |
7 other study(ies) available for cilomilast and zardaverine
| Article | Year |
|---|---|
Novel selective PDE4 inhibitors. 1. Synthesis, structure-activity relationships, and molecular modeling of 4-(3,4-dimethoxyphenyl)-2H-phthalazin-1-ones and analogues.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Inhibitors; Humans; In Vitro Techniques; Leukocytes; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Phthalazines; Structure-Activity Relationship | 2001 |
Synthesis and structure-activity relationships of cis-tetrahydrophthalazinone/pyridazinone hybrids: a novel series of potent dual PDE3/PDE4 inhibitory agents.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Edema; Enzyme Inhibitors; Mice; Phthalazines; Pyridazines; Structure-Activity Relationship | 2003 |
Structural basis for the activity of drugs that inhibit phosphodiesterases.
Topics: Binding Sites; Crystallography, X-Ray; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Structure, Tertiary | 2004 |
In silico search for multi-target anti-inflammatories in Chinese herbs and formulas.
Topics: Anti-Inflammatory Agents; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Databases, Factual; Drug Design; Drugs, Chinese Herbal; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Medicine, Chinese Traditional; Models, Chemical; Models, Molecular; Molecular Conformation; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship | 2010 |
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.
Topics: Administration, Oral; Animals; Drug Design; Female; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Models, Molecular; Molecular Conformation; Phosphodiesterase 4 Inhibitors; Pneumonia | 2012 |
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.
Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship | 2016 |
Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.
Topics: Azepines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Design; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Molecular Structure; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2017 |